G GLENVEIGH PHARMACEUTICALS Trademark

Trademark Overview

On Wednesday, April 6, 2005, a trademark application was filed for G GLENVEIGH PHARMACEUTICALS with the United States Patent and Trademark Office. The USPTO has given the G GLENVEIGH PHARMACEUTICALS trademark a serial number of 78603254. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, September 5, 2014. This trademark is owned by Glenveigh Pharmaceuticals, LLC. The G GLENVEIGH PHARMACEUTICALS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development of pharmaceuticals and of medical diagnostic products
g glenveigh pharmaceuticals

General Information

Serial Number78603254
Word MarkG GLENVEIGH PHARMACEUTICALS
Filing DateWednesday, April 6, 2005
Status710 - CANCELLED - SECTION 8
Status DateFriday, September 5, 2014
Registration Number3376469
Registration DateTuesday, January 29, 2008
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, January 3, 2006

Trademark Statements

Indication of Colors claimedColor is not claimed as a feature of the mark.
Disclaimer with Predetermined Text"PHARMACEUTICALS"
Goods and ServicesResearch and development of pharmaceuticals and of medical diagnostic products

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, September 5, 2014
Primary Code042
First Use Anywhere DateSunday, May 1, 2005
First Use In Commerce DateSunday, May 1, 2005

Trademark Owner History

Party NameGlenveigh Pharmaceuticals, LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressDurham, NC 277135273
Party NameGlenveigh Pharmaceuticals, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressDurham, NC 277135273
Party NameGlenveigh Pharmaceuticals, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressDurham, NC 277135273

Trademark Events

Event DateEvent Description
Friday, September 5, 2014CANCELLED SEC. 8 (6-YR)
Tuesday, September 27, 2011ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, September 27, 2011TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, October 12, 2010TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, January 29, 2008REGISTERED-PRINCIPAL REGISTER
Thursday, December 27, 2007LAW OFFICE REGISTRATION REVIEW COMPLETED
Wednesday, December 26, 2007ASSIGNED TO LIE
Wednesday, November 14, 2007ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, October 5, 2007STATEMENT OF USE PROCESSING COMPLETE
Monday, September 24, 2007USE AMENDMENT FILED
Monday, September 24, 2007TEAS STATEMENT OF USE RECEIVED
Monday, July 16, 2007EXTENSION 2 GRANTED
Wednesday, March 28, 2007EXTENSION 2 FILED
Monday, April 23, 2007ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, April 23, 2007TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, March 28, 2007TEAS EXTENSION RECEIVED
Tuesday, September 26, 2006EXTENSION 1 GRANTED
Tuesday, September 26, 2006EXTENSION 1 FILED
Tuesday, September 26, 2006TEAS EXTENSION RECEIVED
Tuesday, March 28, 2006NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 3, 2006PUBLISHED FOR OPPOSITION
Wednesday, December 14, 2005NOTICE OF PUBLICATION
Wednesday, November 16, 2005LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, November 10, 2005ASSIGNED TO LIE
Tuesday, November 8, 2005APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, November 4, 2005EXAMINER'S AMENDMENT ENTERED
Thursday, November 3, 2005EXAMINERS AMENDMENT E-MAILED
Thursday, November 3, 2005EXAMINERS AMENDMENT -WRITTEN
Wednesday, November 2, 2005ASSIGNED TO EXAMINER
Thursday, April 14, 2005NEW APPLICATION ENTERED IN TRAM

Related Keywords

pharmaceuticals glenveigh diagnostic products medical development research